Badilla NA

Language: Spanish
References: 16
Page:
PDF size: 197.36 Kb.

ABSTRACT

Sarcoidosis is a chronic granulomatous disease mediated by the immune system, characterized by the histological presence of non-caseating granulomas, although its highest prevalence is pulmonary involvement, a percentage is at the level of the nervous system, this being a variable presentation over time. and with compromise of both brain parenchyma and its contained structures mainly hypothalamus and pituitary, central and peripheral cranial nerves, meninges and both arterial and venous blood vessels, with multiple clinical presentations ranging from neuropathic disorders, transverse myelitis, neuroendocrine dysfunction and myopathic conditions. Although most of it is associated with another concomitant organic condition, a small percentage occurs as an isolated manifestation in its clinical presentation, many diagnostic methods are currently available to confirm or rule out this pathology, although the definitive diagnosis is made only by histological verification; There are already established clinical, imaging and laboratory criteria that allow the diagnostic approach to be carried out. Glucocorticoids are the cornerstone of treatment, especially in the acute stage, while steroid-sparing agents are of choice in prolonged therapy to minimize steroid toxicity, while biological agents can help in refractory or severe cases. Neurosarcoidosis is a disease with devastating functional sequelae for the individual who presents it, but a more favorable functional outcome has been shown over time, possibly due to early recognition and aggressive therapy with glucocorticoids and immunosuppressants.

REFERENCES

1. Pawate S. Sarcoidosis and the Nervous System, CONTINUUM (MINNEAP MINN) 2020;26(3, NEUROLOGY OF SYSTEMIC DISEASE):695–715.

2. Albarrán F, Abbasi Pérez A, Pérez Gómez A, Álvarez-Mon Soto M. Sarcoidosis, Medicine. 2021;13(32):1822-34.

3. Shiva Barforoshi BA, Nikhil A. Patel BS, Alvin P, Singh MS, Terrence Li MD, Benjamin MD, A Rare Case of Steroid-Resistant Neurosarcoidosis of the Cavernous Sinus With Optic Neuropathy: A Case Report. The Neurohospitalist. 2021;11(4):356-359. doi: https://doi.org/10.1177/1941874421993644

4. Ungprasert P, Matteson E. Neurosarcoidosis. Rheum Dis Clin N Am. 2017;43:593–606. doi: http://dx.doi.org/10.1016/j.rdc.2017.06.008

5. Scott T. Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis, Journal of the Neurological Sciences. 2021;429:117621. doi: https://doi.org/10.1016/j.jns.2021.117621.

6. Ramos Casals M, Pérez Álvarez R, Kostov B, Gómez de la Torre R, Feijoo Massó C, Chara Cervantes J, et al. Clinical characterization and outcomes of 85 patients with neurosarcoidosis, Scientifc Reports. 2021;11:13735. doi: https://doi.org/10.1038/s41598-021-92967-6

7. Bradshaw M, Pawate S, Koth L, Cho T, Gelfand J. FAAN Neurosarcoidosis Pathophysiology, Diagnosis, and Treatment. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1084. doi: https://doi.org/10.1212/NXI.0000000000001084

8. Ramos-Clemente Romero J, Díaz-Carrasco D. Ataxia como primera manifestación de neurosarcoidosis, Neurolarg. 2016;8(1):68–70. doi: http://dx.doi.org/10.1016/j.neuarg.2015.05.003

9. Nicolosi C, Carrera EJ, Heronemus M, Shivers J, Niehaus W. Neurosarcoidosis in acute inpatient rehabilitation: a case study Spinal Cord Series and Cases. 2020;6:99. doi: https://doi.org/10.1038/s41394-020-00350-w

10. Park B, Ray E, Bathla G, Bruch L, Streit J, Cho T. Single Center Experience with Isolated Spinal Cord Neurosarcoidosis, World Neurosurg. 2021:e1-e10: doi: https://doi.org/10.1016/j.wneu.2021.09.089

11. Sánchez R, Meseguer M, Alonso E, Alandete S. Hallazgos en las pruebas de imagen de la sarcoidosis. Med Clin (Barc). 2021;156(7):349–355.

12. Feizi P, Tandon M, Khan E, Subedi R, Prasad A, Chowdhary A, et al. Overcoming the Elusiveness of Neurosarcoidosis: Learning from Five Complex Cases. Neurol. Int. 2021;13:130–142. doi: https://doi.org/10.3390/neurolint13020013

13. Chavarriaga-Restrepo A, López-Amaya J, Mesa- Navas M, Velásquez-Franco C. Sarcoidosis: muchas caras, una enfermedad. Revisión narrativa de la literatura. 2019 Jul-Sep;32(3):191-203. doi: https://doi.org/10.17533/udea.iatreia.11

14. Vedeler C. Neurosarcoidosis una serie de casos. 22 March 2021. Tidsskr Nor Legeforen. doi: https://doi.org/10.4045/tidsskr .20.0361

15. Carazo Barrios L, Abarca Costalago M, Hidalgo Conde A, Arnedo Díez de los Ríos R, García Portales R, García Martín G. Neurosarcoidosis: análisis de una serie de 20 pacientes. Med Clin (Barc). 2020;155(7):309–312. doi: https://doi.org/10.1016/j.medcli.2020.04.027

16. Bathla G, Abdel-Wahed L, Agarwal A. Vascular Involvement in Neurosarcoidosis, Neurol Neuroimmunol Neuroinflamm. 2021;8:e1063. doi: https://doi.org/10.1212/NXI.0000000000001063